Groundbreaking Study Uncovers Hidden Consequences of Teen Cannabis Use

Researchers at the University of California San Diego have made a groundbreaking discovery that has sent shockwaves through the scientific community. A recent study has found a strong link between teenage cannabis use and slower memory and thinking growth. The study, which was published in the esteemed journal Neuropsychopharmacology, used data from over 11,000 participants in the Adolescent Brain Cognitive Development (ABCD) Study.

The ABCD Study is the largest long-term investigation of brain development among young people in the United States, and the findings of this study are nothing short of astonishing. According to the study, teenagers who start using cannabis may develop memory and thinking abilities more slowly than their peers who do not use it. The researchers found that this slower cognitive growth was particularly evident in areas such as memory, attention, language, and processing speed.

But what exactly does this mean for teenagers who use cannabis? According to Dr. Natasha Wade, the lead author of the study, ‘Adolescence is a critical time for brain development, and what we’re seeing is that teens who start using cannabis aren’t improving at the same rate as their peers.’ Dr. Wade went on to explain that ‘these differences may seem small at first, but they can add up in ways that affect learning, memory, and everyday functioning.’

The researchers used a combination of participant reports and biological tests, including hair, urine, and saliva samples, to accurately measure cannabis exposure. They found that teenagers who used cannabis showed slower improvement across several areas of cognition, including memory, attention, language, and processing speed. In some cases, the participants who used cannabis initially performed as well as, or slightly better than, their peers at younger ages. However, as they grew older and began using cannabis, their cognitive gains tended to level off, while their peers continued to improve.

The study also examined whether specific cannabis compounds were associated with different outcomes. Within a smaller group of participants, teenagers with evidence of tetrahydrocannabinol (THC) exposure, the primary intoxicating compound in cannabis, experienced greater declines in memory performance over time than teens who did not use cannabis. In contrast, the same pattern was not observed among teenagers with evidence of cannabidiol (CBD) exposure, although the number of participants in that group was limited.

Dr. Wade emphasized that ‘these results point to THC as a likely driver of the changes we’re seeing,’ and highlighted how complicated cannabis products can be, especially since some products labeled as CBD may still contain THC. The researchers also noted that the cognitive differences identified in the study were relatively modest, but may still have meaningful effects. The brain develops rapidly during adolescence, so even minor changes in memory, attention, or thinking speed could influence classroom performance, learning, and everyday activities.

The study’s findings do not establish that cannabis directly caused the slower cognitive growth. Environmental conditions, personality traits, and other factors could also contribute to the differences. However, the researchers adjusted their analysis for many possible influences, including family background, mental health, the use of other substances, and each participant’s cognitive abilities before cannabis use began.

The research team plans to continue monitoring the participants as they enter young adulthood. Future analysis may offer a clearer picture of the long-term effects of cannabis and reveal whether the age at which use begins, as well as how often cannabis is used, influences brain development. As Dr. Wade noted, ‘delaying cannabis use supports healthy brain development,’ and ‘as cannabis becomes more widely available, it’s essential for families and teens to understand how it may affect the developing brain.’

The study was funded, in part, by the National Institute on Drug Abuse (DA050779, PI: Wade), (DA064409 PI: Sullivan), (DA062011 PI: Wallace), (T32 AA013525 PI: Riley/Spadoni to Szpak), (R01DA062432 MPI Lisdahl, Hillard), (2U01DA041025 MPI Lisdahl, Larson), (K01DA057389 PI: Gonçalves), and (NARSAD/Brain Behavior Research Foundation Gonçalves).